Drug Shortage Report for NOVAHISTEX DH
Report ID | 41428 |
Drug Identification Number | 02049481 |
Brand name | NOVAHISTEX DH |
Common or Proper name | Novahistex DH 100ml |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE |
Strength(s) | 20MG 5MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL |
Packaging size | 100ml |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-03-21 |
Actual start date | |
Estimated end date | 2018-05-16 |
Actual end date | 2018-05-07 |
Shortage status | Resolved |
Updated date | 2018-05-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-05-08 | French | Compare |
v9 | 2018-05-08 | English | Compare |
v8 | 2018-05-07 | English | Compare |
v7 | 2018-04-04 | French | Compare |
v6 | 2018-04-04 | English | Compare |
v5 | 2018-03-22 | English | Compare |
v4 | 2018-03-15 | French | Compare |
v3 | 2018-03-15 | English | Compare |
v2 | 2018-03-01 | French | Compare |
v1 | 2018-03-01 | English | Compare |
Showing 1 to 10 of 10